Aldesleukin Unknown Status Phase 3 Trials for Leukemias Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00004128Combination Chemotherapy, Interleukin-2, and Peripheral Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia
NCT00149162Treating Patients With Childhood Acute Myeloid Leukemia With Interleukin-2